StonvexLoading…
StonvexStonvexStonvexCore line items from BH.A's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $97.48M | $395.26M | $295.39M | $195.65M |
Operating Income | $-18.88M | $-47.69M | $16.37M | $23.92M |
Net Income | $-14.53M | $-37.49M | $12.37M | $50.93M |
EPS (Diluted) | Not available | $-143.86 | Not available | Not available |
Total Assets | $1.02B | $1.03B | $1.08B | $863.58M |
Total Liabilities | $499.14M | $501.95M | $499.22M | $274.29M |
Cash & Equivalents | $200.07M | $268.78M | $272.49M | $32.77M |
Free Cash Flow OCF − CapEx | $13.37M | $76.61M | $70.24M | $47.94M |
Shares Outstanding | Not available | Not available | Not available | Not available |